HbA1c reduction from baseline (%)

HbA1c relative reduction from baseline (%)

Change in related prevalence of complications

Treatments

1.2 mg Lirag + Glim + Met

−1.3%

−16.67%

−66.67%

1.8 mg Lirag + Glim + Met

−1.4%

−17.95%

−71.79%

Glim 4 g + Met

−1.3%

−16.67%

−66.67%